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adult human neural crest-derived stem cells
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Christian Kaltschmidt1 and Barbara Kaltschmidt2*Abstract
Introduction: Facing the challenging treatment of neurodegenerative diseases as well as complex craniofacial
injuries such as those common after cancer therapy, the field of regenerative medicine increasingly relies on stem
cell transplantation strategies. Here, neural crest-derived stem cells (NCSCs) offer many promising applications,
although scale up of clinical-grade processes prior to potential transplantations is currently limiting. In this study,
we aimed to establish a clinical-grade, cost-reducing cultivation system for NCSCs isolated from the adult human
nose using cGMP-grade Afc-FEP bags.
Methods: We cultivated human neural crest-derived stem cells from inferior turbinate (ITSCs) in a cell culture bag
system using Afc-FEP bags in human blood plasma-supplemented medium. Investigations of viability, proliferation and
expression profile of bag-cultured ITSCs were followed by DNA-content and telomerase activity determination. Cultivated
ITSCs were introduced to directed in vitro differentiation assays to assess their potential for mesodermal and ectodermal
differentiation. Mesodermal differentiation was determined using an enzyme activity assay (alkaline phosphatase, ALP),
respective stainings (Alizarin Red S, Von Kossa and Oil Red O), and RT-PCR, while immunocytochemistry and synaptic
vesicle recycling were applied to assay neuroectodermal differentiation of ITSCs.
Results: When cultivated within Afc-FEP bags, ITSCs grew three-dimensionally in a human blood plasma-derived matrix,
thereby showing unchanged morphology, proliferation capability, viability and expression profile in comparison
to three dimensionally-cultured ITSCs growing in standard cell culture plastics. Genetic stability of bag-cultured
ITSCs was further accompanied by unchanged telomerase activity. Importantly, ITSCs retained their potential to
differentiate into mesodermal cell types, particularly including ALP-active, Alizarin Red S-, and Von Kossa-positive
osteogenic cell types, as well as adipocytes positive in Oil Red O assays. Bag culture further did not affect the
potential of ITSCs to undergo differentiation into neuroectodermal cell types coexpressing β-III-tubulin and MAP2
and exhibiting the capability for synaptic vesicle recycling.
Conclusions: Here, we report for the first time the successful cultivation of human NCSCs within cGMP-grade
Afc-FEP bags using a human blood plasma-supplemented medium. Our findings particularly demonstrate the
unchanged differentiation capability and genetic stability of the cultivated NCSCs, suggesting the great potential
of this culture system for future medical applications in the field of regenerative medicine.* Correspondence: barbara.kaltschmidt@uni-bielefeld.de
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Treatment of neurodegenerative diseases as well as com-
plex injuries, as in cancer or severe accidents, remains
an important challenge in stem cell-based regenerative
medicine, emphasizing the need for clinical-grade trans-
plantation strategies. However, the relative abundances
of available endogenous stem cells in their respective
niches within the human body are too low to achieve
significant therapeutic effects if transplanted directly into
the patient without prior in vitro expansion [1]. Although
there is a clear need for expansion steps prior to trans-
plantation, cultivation of stem cells in vitro presents
the inherent challenges of increasing risk of contamin-
ation, for example by transmitting infectious agents [2]
or bacteria [3].
State-of-the-art stem cell culture approaches include the
use of cost-intensive cleanrooms, which ensure sterility
and, thus, limit the risk of contamination [4]. Culture
bag systems represent a less expensive and more easily
manageable alternative. In the present study, we used
Afc-VueLife bags (2PF-0002, American Fluoroseal Corp.,
Gaithersburg, MD, USA) made of fluoroethylenepropylene
(FEP), with a volume of 2 mL and two luer-ports on either
side. VueLife bags are gas permeable and certified to
clinical-Good Manufacturing Practice (cGMP) grade, as
recommended by the Food and Drug administration
(FDA) for stem cell based products [5]. Applying such
Afc-FEP bags to cell expansion prior to transplantation,
Lima and colleagues showed successful cultivation of
cord blood cells followed by transplantation into ten
patients with advanced hematological malignancies [6].
The suitability of Afc-FEP-bags to cell cultivation was
further demonstrated by Krause et al. using natural
killer cells [7] as well as by Hendrikx and coworkers,
who applied such bags for bone marrow cells before
intramyocardial transplantation [8]. Extending these
promising findings, we applied Afc-FEP bags for the
cultivation of neural crest-derived stem cells isolated
from the adult human nose. Such inferior turbinate
stem cells (ITSCs), which are suggested to possess a
Schwann cell-like character endogenously [9,10], can be
isolated age-independently via a minimally invasive biopsy.
Cultivated in vitro, ITSCs show the ability to self-renew
and differentiate into ectodermal and mesodermal cell
types, indicating their multipotent state [10]. ITSCs may
further offer the possibility to be transplanted autologously
back into their donor, avoiding the need of long-term
immunosuppression. Aiming for a clinical-grade expan-
sion prior to potential future transplantations, we recently
described the application of a human blood plasma (BP)-
based fibrin matrix for cultivation of ITSCs, thus avoiding
the use of animal sera [11]. Although the abandonment
of animal sera is highly recommended by the FDA
[5,12], clinically approvable production processes forITSCs, including the use of cGMP-graded cell culture
containers, is necessary for the safety of the stem cell-
based products [4].
Addressing this challenge, we describe here for the
first time the feasibility of a cGMP-grade Afc-FEP bag
for cultivation of adult neural crest-derived human
stem cells. Bag-cultured ITSCs grew three-dimensionally
within the culture bags in a human BP-based fibrin matrix,
demonstrating no significant changes in morphology,
viability, proliferation, expression profile, genetic stability
or telomerase activity in comparison to cultivation in
three-dimensional cell culture flasks. Cultivation in bags
did not affect the ability of ITSCs to differentiate into
mesodermal or ectodermal cell types, emphasizing the
potential suitability of this bag system for future clinical
applications.
Methods
Isolation and three-dimensional-cell culture of adult
human inferior turbinate stem cells
Isolation of ITSCs was performed according to [10].
Briefly, human nasal inferior turbinates were extracted via
routine nasal surgery after informed consent according
to local and international guidelines (Bezirksregierung
Detmold/Münster). Isolation and further experimental
procedures were ethically approved by the ethics com-
mission of the Ärztekammer Westfalen-Lippe and the
medical faculty of the Westfälische Wilhems-Universität
(Münster, Germany) (approval reference number 2012-
15-fS). Enzymatic dissociation using Dispase II (Sigma-
Aldrich, Taufkirchen, Germany; 0.55 U/mg) for 12 hours
at 4°C was subsequently followed by mechanical disinte-
gration and further enzymatic digestion with collagenase
NB4 (1.17 U/mL; SERVA Electrophoresis, Heidelberg,
Germany) for two hours at 37°C.
ITSCs were precultivated in (Dulbecco’s) modified
Eagle’s medium/Ham’s F-12 (1:1) (DMEM/F-12; Bio-
chrom, Berlin, Germany) with penicillin and streptomycin
(P/S) (0.1 mg/ml penicillin, 100 U/ml streptomycin; PAA,
Pasching, Austria), amphotericin B (AB) (0.25 mg/ml; PAA),
L-glutamine (L-Glu) (200 mM; Sigma-Aldrich), epidermal
growth factor (EGF; 20 ng/mL; R&D Systems, Wiesbaden,
Germany), basic fibroblast growth factor (bFGF-2; 40 ng/
mL; lab-made) and B27 supplement [13], hereinafter re-
ferred to as ‘standard medium,’ as well as additional heparin
(0.5 U/ml, Sigma-Aldrich) at 37°C, 5% CO2 and 5% O2
using a humidified incubator (Binder, Tuttlingen, Germany)
and low adhesion T25 tissue culture flasks (Greiner Bio-One,
Frickenhausen, Germany). After observing primary neuro-
sphere formation, ITSCs were harvested by centrifugation
at 300 × g and dissociated with collagenase NB4 (SERVA
Electrophoresis) for two hours at 37°C.
For three-dimensional-cell culture, harvested ITSCs
were cultivated in standard medium supplemented with
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(Institut für Laboratoriums- und Transfusionsmedizin,
Bad Oeynhausen, Germany) according to Greiner et al.
[11] using a 25 cm2-Tissue Culture Flask or 22.1 cm2-
Tissue Culture Dish (TPP, TechnoPlasticProcducts,
Trasadingen, Switzerland). Passaging was performed
as described above.
Cultivation of ITSCs in Afc-FEP bags
For bag culture, ITSCs isolated as described above were
harvested using collagenase NB4 (SERVA Electrophoresis)
for two hours at 37°C followed by centrifugation at
300 × g. A defined amount of ITSCs was placed in 2 ml
standard medium comprising 10% clinically accredited
therapeutic human BP (Institut für Laboratoriums- und
Transfusionsmedizin). Stem cell-containing medium was
subsequently filled into 2 ml Afc-FEP bags 2PF-0002 (in
the following referred to as ‘cell culture bag’) (Afc,
American Fluoroseal Corp.) using syringes (B. Braun
Melsungen AG, Melsungen, Germany) through a Luer
port at the side of the bag. Cultivation was performed
at 37°C, 5% CO2 and 5% O2 in a humidified incubator
(Binder).
Bag-cultured ITSCs were fed at least every two days by
removal of liquid medium supernatant comprising the
digested BP-matrix via a syringe (B. Braun Melsungen AG)
through the Luer ports. Alternatively, whole culture bags
were prepared for centrifugation by folding at one end
followed by placing them into 50 ml Falcon tubes (fold
down to the bottom). Tubes were centrifuged at 300 × g for
10 minutes, leading to the formation of cell pellets at the
respective end of the bag, which allowed removal of
medium supernatant by a syringe (B. Braun Melsungen
AG) through the opposite Luer ports. Removal of medium
was subsequently followed by injection of standard medium
comprising 10% BP (Institut für Laboratoriums- und
Transfusionsmedizin) up to a total volume of 2 ml.
For passaging, ITSCs were harvested by centrifugation
as described above and digested within the culture bags
by adding 2 ml collagenase NB4 (SERVA Electrophoresis)
for one hour at 37°C followed by a second centrifugation
step. Alternatively, liquid medium supernatant was re-
moved as described above followed by the addition of
collagenase NB4 for one hour at 37°C and centrifugation.
Harvested ITSCs were resuspended in 500 μl standard
medium and injected in a new culture bag via syringe
followed by addition of standard medium and 10% BP up to
a total volume of 2 ml. Cultivation was performed at 37°C,
5% CO2 and 5% O2 in a humidified incubator (Binder).
Transfection of cultivated ITSCs
ITSCs were cultivated under standard conditions,
digested with collagenase NB4 (SERVA Electrophoresis)
and harvested via centrifugation. Afterwards, ITSCswere transfected with 1 μg pmax GFP (Amaxa Biosys-
tems, Lonza Group AG, Basel, Switzerland) using
Amaxa rat NSC-Nucleofector Kit (Amaxa Biosystems)
and Nucleofector II device (Amaxa Biosystems) accord-
ing to the manufacturer’s guidelines.
Immediate addition of 5 ml DMEM/F-12 (Sigma-Al-
drich) was followed by centrifugation for 10 minutes at
300 × g. Transfected ITSCs were suspended in 2 ml stand-
ard medium supplemented with 10% BP and injected into
Afc-FEP bags 2PF-0002 (Afc) using a syringe (B. Braun
Melsungen AG). Cultivation was performed at 37°C, 5%
CO2 and 5% O2 for 48 hours in a humidified incubator
(Binder). Live imaging of GFP-ITSCs was done via optical
sectioning (Z-Stack) using confocal laser scanning micros-
copy (excitation wavelength: 488 nm, LSM 510, Carl Zeiss,
Jena, Germany), while ZEN software (Carl Zeiss) was sub-
sequently applied for three-dimensional reconstruction.
Proliferation assay and vitality measurement of ITSCs
A defined number of ITSCs was cultured in Afc-FEP
bags 2PF-0002 (Afc) or 9.2 cm2 Tissue Culture Dishes
(TPP) in standard medium supplemented with 10% BP
for five days as described above. For determination of
total cell numbers, counting was performed after diges-
tion with collagenase NB4 (SERVA Electrophoresis) and
harvesting at 300 × g, in a Cellometer Auto T4 device
(Nexcelom Bioscience, Lawrence, MA, USA). The vital-
ity of the cultured cells was assessed using trypan blue
staining (Sigma-Aldrich) according to the manufacturer’s
guidelines followed by measurement with a Cellometer
Auto T4 device (Nexcelom Bioscience). Doubling time
was calculated according to the formulas (doubling time =
ln(2)/growth rate) and [(ell amount = cell concentra-
tion (t = 0)*egrowth rate*time). Statistical analysis of cell
proliferation and vitality was performed with Graph
Pad Prism (GraphPad Software, San Diego, CA, USA).
Reverse transcription PCR
Total RNA was isolated using TRI Reagent (Sigma-Al-
drich) or innuPREP RNA mini Kit (Biometra GmbH,
Analytik Jena AG, Jena, Germany) according to the
manufacturers’ guidelines followed by assessment of RNA-
concentration and quality via Nanodrop UV spectropho-
tometry. For subsequent cDNA synthesis, the First Strand
cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany)
or qScript cDNA synthesis Kit (Quanta Biosciences Inc.,
Gaithersburg, MD, USA) were applied according to the
manufacturers’ guidelines. PCR was performed using
GoTaq DNA polymerase (Promega, Madison, WI, USA)
as indicated by the manufacturer, including application of
10 mM dNTPs (New England Biolabs, Frankfurt am Main,
Germany) and 0.5 μM primers (see Table 1) (Metabion,
Martinsried, Germany). Water was used instead of cDNA
for negative controls.
Table 1 Primer sequences
Target Forward primer Reverse primer
cMyc aggagacatggtgaaccagagt agcctgcctcttttccacagaaac
Sox2 aaccccaagatgcacaactc gcttagcctcgtcgatgaac
p75 tgagtgctgcaaagcctgcaa tctcatcctggtagtagccgt
Nestin cagcgttggaacagaggttg gctggcacaggtgtctcaag
GAPDH ctgcaccaccaactgcttag gtcttctgggtggcagtgat
Osteocalcin ctcacactcctcgccctatt cgcctgggtctcttcactac
Osteopontin actgattttc ccacggacct cattcaactcctcgctttcc
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For cell cycle analysis, the DNA content of ITSCs was
measured with CyStain PI absolute T-Kit (PARTEC,
Münster, Germany) according to the manufacturer’s
guidelines after at least three weeks of bag- or three-
dimensional-culture. PI-staining was analyzed using a
CyFlow space flow cytometer (PARTEC), while data
analysis was assessed using FlowJo Software (TreeStar,
Olten, Switzerland). Doublet discrimination was done
by gating FL3-A- versus FL3-W signals [14].
Telomerase activity measurement
Telomerase activity of bag cultured ITSCs was analyzed
using the real-time Q-TRAP assay described in [15]. Briefly,
ITSCs cultivated in bags were harvested via collagenase
treatment as described above followed by centrifugation
(3,000 × g, five minutes) and lysis using NP-40 lysis buffer
[15] for 30 minutes. After centrifugation at 16,000 × g for
20 minutes at 4°C, protein concentrations were assessed via
Nanodrop UV spectrophotometry. For real-time Q-TRAP,
the reaction mixture was prepared by adding 2 μl protein
lysate to 12 μl PERFECTa SYBR Green Super Mix (Quanta
Biosciences Inc.), 9 μl H2O, 1 μl ACX primer (5′-GCGCG
GCTTACCCTTACCCTTACCCTAACC-3′, 100 ng/μl,
Sigma-Aldrich) and TS primer (5′-AATCCGTCGAGCA-
GAGTT-3′, 100 ng/μl, Sigma-Aldrich). Prior to qPCR,
reaction mixtures were incubated for 30 min at 25°C to
allow substrate extension by telomerase. Subsequent qPCR
reactions were performed according to guidelines of PER-
FECTa SYBR Green Super Mix Kit (Quanta Biosciences
Inc.) and assayed with Rotor Gene 6000 (QIAGEN, Hilden,
Germany). All reactions were performed in triplicate; U251
cells cultivated as described in [16] served as a positive
control. Respective Ct-values−1 normalized to applied
protein concentrations served for calculating relative
telomerase activity of ITSCs as percentage telomerase
activity to positive control (positive control equal to 100%
telomerase activity). Statistical analysis was performed
with Graph Pad Prism (GraphPad Software).
Directed osteogenic differentiation assay
For directed osteogenic differentiation, bag- and three-
dimensional-cultured ITSCs were harvested as describedabove and 3 × 103 cells/cm2 were plated on 12-well TPP
tissue culture plates (TPP) in DMEM (Sigma-Aldrich)
containing 10% FCS (Sigma-Aldrich, lot: 126 K3398).
ITSCs were cultivated at 37°C and 5% CO2 for 48 hours.
Afterwards, medium was replaced by osteogenic differ-
entiation medium including DMEM (Sigma-Aldrich)
supplemented with 10% FCS, 100 nM dexamethasone
(Sigma-Aldrich), 10 mM β-glycerophosphate (Sigma-
Aldrich) and 0.55 mM L-ascorbic acid-2-phosphate
(Sigma-Aldrich). Feeding was performed every three
to four days with fresh osteogenic differentiation med-
ium. ALP activity was assessed after 9 days of differen-
tiation, while RT-PCR-analyses as well as Alizarin Red
S and Von Kossa staining were applied after differenti-
ation for 21 days.
Detection of alkaline phosphatase-activity
The ALP activity of ITSCs precultivated as bag- and three
dimensional-culture ITSCs was measured after nine days
of osteogenic differentiation. Differentiated ITSCs were
fixed with 4% PFA (Paraformaldehyde) followed by staining
using a freshly prepared staining solution comprising two
parts Fast Red Violet (Sigma-Aldrich), one part Naphtol
AS-MX phosphate alkaline solution (Sigma-Aldrich) and
two parts ddH2O. The staining solution was incubated for
15 minutes under exclusion of light followed by determin-
ation of ALP activity via light microscopy using an AMG
EVOS xl microscope (PeqLab Biotechnology).
Alizarin Red S and Von Kossa staining for assessment of
osteogenic differentiation
Alizarin Red S and Von Kossa stainings were applied
after 21 days of osteogenic differentiation of bag- and
three-dimensional-cultivated ITSCs. For Alizarin Red S
staining, fixation with 4% PFA for 15 minutes was
followed by washing with PBS (1x) and subsequent
staining using 1% Alizarin Red Solution (Sigma-Aldrich)
for 5 minutes. Von Kossa staining was performed after
fixing differentiated ITSCs with 4% PFA for 15 minutes
followed by washing with ddH2O. After application of
5% silver nitrate in ddH2O (Fluka Chemie, Buchs,
Switzerland) for 60 minutes under UV-light and subse-
quent washing with ddH2O, 5% sodium thiosulfate
(Fluka Chemie) was applied for three minutes at room
temperature. The third washing step was followed by
staining with 0.1% nuclear fast solution comprising 5%
aluminum sulfate and 0.1% nuclear fast red (Merck
KGaA, Darmstadt, Germany) dissolved in ddH2O for
five minutes. The final washing was performed using
100% ethanol (Sigma-Aldrich) and two times using 96%
ethanol. Imaging of Alizarin Red S and Von Kossa
stained ITSCs was done via light microscopy using
AMG EVOS xl microscope (PeqLab Biotechnology).
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ITSCs pre-cultured in cell culture bags (Afc) or three-
dimensionally as described above were plated at a dens-
ity of 4 × 103 cells per well in 12-well TPP tissue culture
plates (TPP) and cultivated for 48 hours in DMEM
(Sigma-Aldrich) containing 10% FCS (Sigma-Aldrich, lot:
126 K3398). Afterwards, the medium was replaced by
DMEM comprising 10% FCS (Sigma-Aldrich), 1 μM
dexamethasone (Sigma-Aldrich), 2 μM insulin (Sigma-
Aldrich), 500 μM 3-isobutyl-1-methylxanthine (Sigma-
Aldrich) and 200 μM indomethacin (Sigma-Aldrich).
ITSCs were cultivated up to 28 days under differentiation
conditions, while medium was changed every three days.
To assess adipogenic differentiation, ITSCs were fixed
with 10% PFA for 60 minutes followed by staining with
freshly prepared Oil Red O solution (Sigma-Aldrich) (0.5%
Oil Red O in propanol) for two hours.
Directed neuronal differentiation
For neuronal differentiation, three-dimensional- or bag-
cultured ITSCs were seeded in 12-well TPP tissue
culture plates (TPP) at a density of 1×105 cells/well and
cultivated in DMEM (Sigma-Aldrich) containing 10%
FCS (Sigma-Aldrich, lot: 126 K3398). After 48 hours,
1 μM dexamethasone (Sigma-Aldrich), 2 μM insulin
(Sigma-Aldrich), 500 μM 3-isobutyl-1-methylxanthine
(Sigma-Aldrich), 200 μM indomethacin (Sigma-Aldrich)
and 200 mM ethanol were added to the medium to in-
duce neuronal differentiation. Medium was additionally
supplemented with 0.5 μM retinoic acid and N2 supple-
ment after seven days of differentiation, while medium
change was performed twice a week by replacing half of
the medium volume. After 28 days, immunocytochem-
ical stainings and vesicle recycling assay were performed.
Immunocytochemistry of differentiated ITSCs
For immunocytochemistry, ITSCs were cultivated under
neuronal differentiation conditions for 28 days. After fix-
ation using 4% phosphate buffered 4% PFA, ITSCs were
permeabilized with 0.02% Triton X-100 (Sigma-Aldrich)
in PBS for 30 minutes at room temperature. Blocking
was performed using 5% of the appropriate normal serum
followed by addition of the primary antibodies anti-β-III-
Tubulin (1:300, Promega) and anti-microtubule-associated
protein 2 (MAP2, 1:100, Merck Millipore, Billerica, MA,
USA) for two hours. Secondary fluorochrome-conjugated
antibodies Alexa Fluor® 488 donkey anti-rabbit IgG (1:300,
Invitrogen) and anti-mouse (1:300, Invitrogen) were
applied for one hour at room temperature under exclu-
sion of light. Nuclear counterstaining was performed
using 4',6-diamidino-2-phenylindole (DAPI, 0.5 μg/ml;
Sigma-Aldrich) for 15 minutes. Fluorescence imaging was
performed using confocal laser scanning microscopy
(LSM 510 or LSM 780, Carl Zeiss).Vesicle recycling
To assess the capabilitiy of ITSCs differentiated for
28 days in neuronal induction medium for synaptic
vesicle recycling, FM1-43FX Lipophilic Styryl Dye (Life
Technologies, Molecular Probes, Paisley, UK) was ap-
plied according to the manufacturer’s guidelines. Subse-
quent washing of the cells using Hank’s balanced salt
solution (HBSS) (Sigma-Aldrich) was followed by stain-
ing for 90 seconds with FM1-43FX dye containing
75 mM KCl. Imaging was performed using fluorescence
microscopy (AxioVert, Carl Zeiss).
Results
Afc-FEP cell culture bags are suitable for three-dimensional-
cultivation of human ITSCs
In order to investigate the potential suitability for ITSC-
expansion, Afc-FEP bags were filled with stem cell-
containing medium supplemented with human BP
(Figure 1A). Subsequent formation of a BP-based fibrin
matrix as well as successful growth of ITSCs was ob-
servable within the bags, wherein ITSCs revealed char-
acteristically long-shaped cell bodies (Figure 1B) [10,11].
To further elucidate the distribution of ITSCs growing
within the cell culture bags, ITSCs were transiently trans-
fected with GFP. GFP-signals were determined by con-
focal laser scanning microscopy using optical sectioning
(Z-stack) followed by subsequent three-dimensional-
reconstruction. ITSCs were found to be localized within
all three-dimensions of the fibrin matrix, suggesting
homogenous, three-dimensional-growth within the culture
bags (Figure 1C).
Bag culture does not impair viability and proliferative
capability of ITSCs
As it is crucial to ITSC-cultivation that fast expansion
occurs, we investigated their viability and ability to pro-
liferate during bag-culture. Here, trypan blue staining
revealed no significant changes in viability between bag-
(94.2% ± 3.56) and three-dimensional-cultured (86.98% ±
3.39) ITSCs (Figure 2A, left diagram). Proliferation of
ITSCs during bag culture was determined by assessing
total cell numbers of ITSCs from three donors over a
defined period of time. Bag-cultured ITSCs demonstrated
no significant change in doubling time (35.76 hours ± 2.47)
in comparison to three-dimensional-cultures (38.98 hours ±
10.04) (Figure 2A, right diagram).
ITSCs maintain their expression profile and genetic
stability during bag-culture
Determining potential influences of bag cultivation on the
expression profile of ITSCs, the messages of respective
stemness and neural crest markers were assessed using
RT-PCR. In comparison to three-dimensional culture,
ITSC-populations derived from three donors revealed
Figure 1 ITSCs grow three-dimensionally in clinical grade culture bags. (A) Afc-FEP bag containing ITSCs in medium supplemented with
human blood plasma. (B) Phase contrast microscopy image of bag-cultured ITSCs revealing characteristic morphology comprising long-shaped
cell bodies. (C) Confocal laser scanning microscopy analyses (Z-sectioning) followed by three-dimensional-reconstruction showed three-dimensional-
growth of bag-cultured ITSCs previously transfected with GFP. FEP, fluorinated ethylene propylene; ITSCs, inferior turbinate stem cells.
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and Sox2 after bag cultivation. We further observed the
messages of neural crest markers p75 and Nestin in
three-dimensional- and bag-cultivated ITSCs, evidencing
a maintained ITSC-characteristic expression profile during
bag cultivation (Figure 2B).
As in vitro cultivation steps may be further associated
with potential changes in ploidy [17], the genetic stability
of ITSCs was determined after three weeks of bag culti-
vation. Propidium iodide (PI) staining followed by sub-
sequent flow cytometric analysis demonstrated typical
DNA content for diploid cells in bag-cultivated cells.
We observed no signs of polyploidy, as indicated by the
lack of detectable PI signal above the G2/M peak. Notably,
ITSCs cultivated in bags showed elevated signals for
apoptotic (sub G1) as well as mitotic cells (G2/M) in
comparison to three-dimensional culture (Figure 2C).
Subculture of ITSCs in bags does not affect their
telomerase activity
Since expansion of adult human stem cells in vitro is
broadly associated with telomere length-dependent aging
[18], we investigated telomerase activity in ITSCs during
bag subculture using real time Q-TRAP analysis [15]. As
depicted in Figure 2D, ITSCs cultivated in bags over ten
passages showed no significant changes in relative tel-
omerase activity (19.60 ± 0.68% of control U251 human
astroglioma tumor cells) compared to early passage bag
cultures (19.84 ± 0.36%).ITSCs cultivated in bags show efficient osteogenic
differentiation capability in a directed differentiation assay
Investigating potential changes in the stemness character-
istics of ITSCs after bag cultivation, we applied a directed
osteogenic differentiation assay by exposing the cells to
dexamethasone, β-glycerophosphate and L-ascorbic acid-
2-phosphate (see Figure 3A for schematic overview).
We assessed the potential activity of ALP, a hallmark of
early osteogenic differentiation, after nine days of dif-
ferentiation. Bag-cultured ITSCs exhibited ALP activity
(Figure 3B, left panel) comparable to three-dimensionally
pre-cultivated ITSCs (data not shown), while control
cells exposed to FCS only remained ALP negative (data
not shown). ITSCs pre-cultivated in bags revealed calcium
deposition after 23 days of directed differentiation, as
shown by Alizarin Red S staining (Figure 3B, middle
panel), indicating late osteogenic differentiation. Von
Kossa staining further substantiated mineralization of
three-dimensional pre-cultivated (data not shown) and
bag-cultured ITSCs (Figure 3B, right panel). On the
contrary, control cells cultivated in FCS-containing me-
dium without additional factors for 23 days displayed no
signs of mineralization (data not shown).
Analyzing osteogenic differentiation of bag-cultured
ITSCs in more detail, we assessed potential expression
of respective osteogenic markers via reverse transcrip-
tion PCR. Differentiated ITSCs, which had been three-
dimensional cultured before differentiation, showed the
message of characteristic osteogenic markers osteopontin
Figure 2 Bag-culture does not affect vitality, expression profile, DNA content and telomerase activity of ITSCs. (A) The amount of trypan
blue-negative ITSCs (viability) and total cell numbers (doubling time) during bag- and three-dimensional-culture reveals no significant changes in
vitality and proliferation (biological triplicates, P <0.05 is considered statistically significant; unpaired t-test, two-tailed, confidence interval: 95%;
dots represent doubling times of ITSCs derived from separate donors). (B) Reverse transcription PCR analysis revealing unchanged expression of
ITSC-specific neural crest and stemness transcripts in bag-cultivated ITSCs. (C) Representative flow cytometric analyses of PI-stained ITSCs after
three weeks of bag- or three-dimensional-culture. Bag-cultured ITSCs exhibited a characteristic DNA content for diploid cells without any signs
of polyploidy, although showing increased signals for apoptotic (sub G1) and mitotic cells (G2/M). (D) Real time Q-TRAP analysis depicting telomerase
activity of ITSCs cultivated in bags over five passages (p5) and no significant changes during subcultivation up to passage 10 (p10) (technical triplicates,
P <0.05 is considered statistically significant; unpaired t-test, two-tailed, confidence interval: 95%). U251 human astroglioma tumor cells served
as positive control, negative control lacked template, n.d.: not detectable. ITSCs, inferior turbinate stem cells; PI, propidium iodide.
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undifferentiated ITSCs cultivated as neurospheres. Not-
ably, ITSCs previously cultivated in culture bags also
expressed osteocalcin and osteopontin after differenti-
ation, further suggesting the presence of osteogenic cell
types (Figure 3C).ITSCs give rise to adipogenic cell types after bag-culture
In addition to osteogenic differentiation, we determined
the capability of bag-cultured ITSCs to give rise to adipo-
genic cell types in a directed differentiation assay. After
30 days of differentiation, formation of Oil Red O-positive
lipid droplets indicated successful adipogenic differentiation
of bag-cultured ITSCs (Figure 3D). We observed no sig-
nificant differences between the adipogenic differentiationpotential of three-dimensional- and bag-cultured ITSCs
(data not shown).Bag-cultured ITSCs maintain their ability to differentiate
into neuronal cells
In order to assess their potential for neuronal differenti-
ation, ITSCs previously cultivated in culture bags were
exposed to directed neuronal differentiation conditions
for four weeks (Figure 4A). Differentiated ITSCs revealed
characteristic neuronal morphology accompanied by co-
expression of the neuronal markers MAP2 and β-III-
tubulin, as shown by immunocytochemistry (Figure 4B).
The capacity of bag-cultured ITSCs to give rise to neur-
onal cell types was found to be comparable to three-
dimensionally pre-cultivated ITSCs (data not shown).
Figure 3 Bag-cultured ITSCs keep their potential to undergo mesodermal differentiation. (A) Schematic overview of directed osteogenic
and adipogenic differentiation assays. (B) Representative phase contrast microscopy images (biological triplicate) revealing ALP-activity (left panel)
as well as Alizarin Red S-(middle panel) and Von Kossa-positive (right panel) Ca2+-deposition of ITSCs cultivated under osteogenic differentiation
conditions after bag culture. (C) RT-PCR analyses show expression of characteristic osteogenic markers osteocalcin and osteopontin in bag-cultured
ITSCs after directed osteogenic differentiation. GAPDH served as loading control. (D) Representative phase contrast microscopy images (biological
triplicate) exhibiting the presence of Oil Red O-positive lipid droplets within adipogenically differentiated ITSCs after bag-culture. ALP, alkaline
phosphatase; ITSCs, inferior turbinate stem cells.
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ITSCs was investigated via a synaptic vesicle recycling
assay using the FM1-43FX dye (Figure 4C). We applied
undifferentiated bag-cultured ITSCs as a negative control,
which demonstrated no labeling above background level
after KCl-dependent stimulation (Figure 4D, upper panel).
On the contrary, ITSCs cultivated in bags followed bydifferentiation for four weeks demonstrated active vesicle
uptake, indicating the presence of at least partly functional
neurons (Figure 4D, lower panel).
Discussion
This study describes, for the first time, the suitability of
Afc-FEP cell culture bags for the cultivation of human
Figure 4 ITSCs maintain neuronal differentiation capacity after bag culture. (A) Schematic overview of directed neuronal differentiation
of ITSCs. (B) Representative immunocytochemical analyses (biological triplicate) showed coexpression of neuronal markers β-III-tubulin and MAP2
in bag-cultured ITSCs after four weeks of directed neuronal differentiation. (C) Schematic view on synaptic vesicle recycling assay. (D) Synaptic
vesicle recycling assay revealed no FM1-43FX signal in undifferentiated ITSCs (upper panel), while bag-cultured ITSCs differentiated for 30 days
were able to recycle synaptic vesicles, as visualized by FM1-43FX-labeling (lower panel). Representative images of biological triplicate. ITSCs, inferior
turbinate stem cells; MAP2, microtubule-associated protein 2.
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derived fibrin matrix. We have demonstrated that ITSCs
maintain their proliferative capability, vitality, expression
profile, genetic stability and telomerase activity during
their expansion within the bags. After bag-culture,
ITSCs were able to give rise to osteogenic, adipogenic
and neuronal cell types.
Residing in the adult human body, neural crest-derived
stem cells (NCSCs) can be isolated from a broad range
of tissues, particularly including dental pulp, periodontalligament, palate and skin as well as oral, respiratory and
olfactory mucosa [10,19-25]. NCSCs are promising candi-
dates for regenerative medicine [25] as they are easily
accessible and expandable in vitro, and maintain robust
differentiation capabilities [20,26-29]. Application of NCSCs
in therapeutic approaches further offers the possibility
to transplant them autologously into their donor, while
additionally avoiding ethical issues. As the low amount
of NCSCs within their respective niches of the adult
human body limits their direct use for transplantations,
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necessary cultivation procedures greatly increase the
risk of transmitting infectious agents [2], such as viruses
[30,31] or bacteria [3] together with the transplant. In
this regard, the FDA, as well as respective bodies of the
European Union (Euro GMP guidelines), prescribe good
tissue handling practices in a sterile environment with
minimal contamination risk as well as recommend against
the use of animal-derived sera [5,12,32].
In terms of avoiding the application of animal sera, we
recently reported the suitability of a human BP-derived
fibrin matrix for cultivation of ITSCs. While a fibrinous
nanofiber network allowed their three-dimensional growth
and fast proliferation, ITSCs were shown to maintain
inherent stemness characteristics, including the ability
to give rise to mesodermal and ectodermal cell types [11].
In addition, application of human BP presents the possi-
bility of autologous and personalizable ITSC expansion, as
ITSCs and BP can be derived from the same patient.
Next to avoidance of animal-derived sera for stem cell
cultivation, clinical-grade sterile culture conditions must
be assured. These conditions are practically limited to
cost intensive cleanrooms with airlocks which require
highly trained personnel. In contrast to cleanrooms,
application of the Afc-FEP cell culture bags used here
is cost-reducing and allows easy handling, while luer ports
allow sterile docking to a completely closed culture
system. Expansion of cells using Afc-FEP culture bags
minimizes the risk of virus infections or bacterial con-
tamination; this was demonstrated by Luhm et al. forFigure 5 Schematic view of potential clinical application of ITSC bag
followed by expansion of ITSCs within Afc-FEP cell culture bags containing
plasma. Cultivation within cell culture bags may be directly followed by tra
stem cells.large-scale generation of natural killer lymphocytes [33].
In addition, Krause and coworkers used 250 ml cell cul-
ture bags to cultivate peripheral blood lymphocytes for
treatment of colon and lung cancer patients in a clinical
phase I trial [7]. Further demonstrating the suitability of
Afc-FEP bags for clinical grade cell cultivation, Lima et al.
showed successful bag culture of cord blood cells followed
by their transplantation into ten patients with advanced
hematological malignancies [6]. Notably, expansion within
culture bags was also reported to be feasable for bone
marrow cells for three weeks before intramyocardial trans-
plantation. Retransplanted cells caused no infusion-related
toxicities, such as allergic reactions, respiratory distress or
hypertensive responses [8], suggesting the suitability of the
future application of Afc-FEP bags, which were used for
ITSCs cultivation in the present study, for cell expansion
prior to transplantation.
Conclusions
In summary, we demonstrate here, for the first time, the
successful cultivation of neural crest-derived human
stem cells within clinical GMP-graded Afc-FEP bags
using a human BP-supplemented medium. Apart from
assuring their vitality and genetic stability, our findings
emphasize the unchanged differentiation capability of
the cultivated NCSCs, particularly including the ability
to give rise to osteogenic and adipogenic, as well as
neuronal cell types.
Given these promising findings, we suggest that there is
great potential of the presented bag system for cultivationculture. Isolation of ITSCs and patient-specific blood plasma may be
cGMP-grade medium supplemented with 10% autologous blood
nsplantion of ITSCs back into the patient. ITSCs, inferior turbinate
Greiner et al. Stem Cell Research & Therapy 2014, 5:34 Page 11 of 12
http://stemcellres.com/content/5/2/34of ITSCs for future clinical applications. As schematically
depicted in Figure 5, ITSCs may be isolated via minimally
invasive surgery, and BP can be derived from the same pa-
tient. Subsequent expansion of ITSCs may be performed
within Afc-FEP cell culture bags using FDA-approved
cGMP-grade medium supplemented with autologous
blood plasma. Expanded ITSCs may be directly trans-
planted back into their donor, representing a potentially
valuable clinical procedure for treating severe craniofacial
injuries or damaged nervus facialis.
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